Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6192)
  2. Meeting Abstract (6164)
  3. Review (400)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (159)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11088)
  2. Hematologic Malignancies, Division of (10639)
  3. GSK Faculty (5447)
  4. Adult Leukemia (3722)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (944)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (310)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (267)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1668)
  3. Nature Publishing Group (1117)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13546)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cytologic findings of marginal zone lymphoma: A study of 14 specimens
    Meeting Abstract

    Crapanzano, J. P.; Lin, O.
    Modern Pathology (2003)

    Fulltext@MSK | Save
  • Cytologic findings of marginal zone lymphoma: A study of 14 specimens
    Meeting Abstract

    Crapanzano, J. P.; Lin, O.
    Laboratory Investigation (2003)

    Fulltext@MSK | Save
  • Serious complications following unrelated donor marrow collection: Experiences of the National Marrow Donor Program (R)
    Meeting Abstract

    Confer, D. L.; Leitman, S. F.; Papadopoulos, E. B.; Price, T. H.; Stroncek, D. F.; Robinett, P.; Braem, B.
    Blood (2003)

    Fulltext@MSK | Save
  • Doxorubicin and dexamethasone (AD) followed by thalidomide and dexamethasone (TD) as initial therapy for symptomatic patients with multiple myeloma
    Meeting Abstract

    Comenzo, R. L.; Hassoun, H.; Reich, L.; Klimek, V.; Kewalramani, T.; Dhodapkar, M.; Drake, L.; Hedvat, C.; Teruya-Feldstein, J.; Fleisher, M.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • The BEXXAR (R) therapeutic regimen (Tositumomab and Iodine I 131 tositumomab) produced durable complete remissions in heavily pretreated patients with non-Hodgkin's lymphoma (NHL), rituximab-relapsed/refractory disease, and rituximab-naive disease
    Meeting Abstract

    Coleman, M.; Kaminski, M. S.; Knox, S. J.; Zelenetz, A. D.; Vose, J. M.
    Blood (2003)

    Fulltext@MSK | Save
  • Optimization of human CD34 positive cell transduction using PG13 retroviral vector supernatant produced under serum free condition
    Meeting Abstract

    Budak-Alpdogan, T.; Przybylowski, M. D.; Fan, Y.; Sadelain, M.; Bertino, J. R.; Riviere, I.
    Blood (2003)

    Fulltext@MSK | Save
  • Allogeneic bone marrow transplantation (BMT) for the treatment of children with very high risk acute lymphoblastic leukemia (ALL) in first remission (CR1)
    Meeting Abstract

    Boulad, F.; Steinherz, P. G.; Kernan, N. A.; Small, T. N.; Prasad, V. K.; Prockop, S. E.; Kolb, A.; O'Reilly, R. J.
    Blood (2003)

    Fulltext@MSK | Save
  • Expression and modulation of the inhibitory Fc gamma receptor, Fc gamma RIIb (CD32b), on human dendritic cells (DCs)
    Meeting Abstract

    Boruchov, A. M.; Young, J. W.
    Blood (2003)

    Fulltext@MSK | Save
  • Design, synthesis and SAR of actinonin analogs
    Meeting Abstract

    Borella, C. P.; Bornmann, W. G.; Scheinberg, D. A.; Sirotnak, F.; Lee, M.
    Abstracts of Papers of the American Chemical Society (2003)

    Fulltext@MSK | Save
  • Assessment of treatment-related myelodysplastic syndromes (tMDS) and acute myeloid leukemia (tAML) in patients with low-grade non-Hodgkin's lymphoma (LG-NHL) treated with tositumomab and iodine-131 tositumomab (the BEXXAR (R) therapeutic regimen)
    Meeting Abstract

    Bennett, J. M.; Kaminski, M. S.; Knox, S. J.; Zelenetz, A. D.; Leonard, J. P.; Vose, J. M.; Horning, S.
    Blood (2003)

    Fulltext@MSK | Save